comparemela.com

The effect of imatinib on mortality from chronic myelogenous leukemia (CML) has not been assessed even though there have been a lot of reports regarding the improvement it has caused on survival outcomes of CML patients. A reduction in mortality is not implied just due to a survival benefit in clinical trials. The researchers collected

Related Keywords

Japan , ,Program Of The National Cancer Institute ,End Results ,National Cancer Institute ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.